ASBP

Aspire Biopharma Holdings, Inc. ASBP

ASBP
Aspire Biopharma Holdings, Inc. PALI
Palisade Bio, Inc. CRIS
Curis, Inc. LPTX
Leap Therapeutics, Inc. ENTO
Entero Therapeutics, Inc. CTXR
Citius Pharmaceuticals, Inc. DARE
Daré Bioscience, Inc. BCTX
BriaCell Therapeutics Corp. PCSA
Processa Pharmaceuticals, Inc. ADTX
Aditxt, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ASBP PALI CRIS LPTX ENTO CTXR DARE BCTX PCSA ADTX
6M -59.52 % 203.16 % -51.61 % 314.45 % 89.21 % -33.28 % -17.80 % -72.39 % -46.58 % -99.38 %
YTD -99.16 % 18.28 % -75.24 % -63.66 % 35.57 % -79.37 % -32.61 % -90.70 % -84.41 % -99.98 %
1Y -99.16 % 24.29 % -66.56 % -60.74 % 39.15 % -75.81 % -34.24 % -89.93 % -85.33 % -99.98 %
3Y -99.16 % -91.85 % -88.83 % -72.98 % -98.74 % -96.02 % -78.47 % -98.74 % -99.40 % -100.00 %
5Y -99.16 % -99.94 % -99.33 % -94.71 % -100.00 % -97.01 % -86.20 % -98.68 % -99.90 % -100.00 %
10Y -99.16 % -100.00 % -99.63 % -98.51 % -100.00 % -99.88 % -99.50 % 5 226.92 % -99.56 % -100.00 %
From the beginning -99.16 % -100.00 % -99.96 % -98.51 % -100.00 % -99.79 % -99.74 % 1 644.55 % -99.96 % -100.00 %

Dividend